13F filer · CIK 1045810 ↗
Nvidia Corp
You are looking at Q4 2024. See the latest, Q2 2026 →
Reported value
$304.5M
−30% on the quarter before
Positions
5
2 new · 3 sold out
Top 10
100.0%
of the value
Est. gain
−$25.0M
on stocks held all quarter
Est. return
−9.2%
on those stocks since Q3 2024
Positions as of Dec 31, 2024, from Nvidia Corp's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q3 2024. Striped tiles are options.
Largest buys
Since Q3 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Nebius Group N.V.~$33.0MNew · 0.0% → 10.8%+1,190,476 shares
- Weride Inc~$24.7MNew · 0.0% → 8.1%+1,738,563 shares
Largest sells
Since Q3 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Arm Holdings Plc~$106.0MCut · 64.8% → 44.6%−859,535 shares
- Serve Robotics Inc~$29.6MSold out · 6.8% → 0.0%−3,727,033 shares
- SoundHound AI~$8.1MSold out · 1.9% → 0.0%−1,730,883 shares
- Nano X Imaging Ltd~$362,563Sold out · 0.1% → 0.0%−59,632 shares
Holdings
As of Dec 31, 2024. Changes are in shares against Sep 30, 2024, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Arm Holdings PlcSPONSORED ADS · shares −44% · price −13.7% | 44.6% | $135.9M | −$21.6M | ||||||||
| Applied Digital CorpCOM NEW · shares 0% · price −7.4% | 19.4% | $59.0M | −$4.7M | ||||||||
| Recursion Pharmaceuticals InCL A · shares 0% · price +2.6% | 17.1% | $52.1M | +$1.3M | ||||||||
| Nebius Group N.V.SHS CLASS A · shares New | 10.8% | $33.0M | — | ||||||||
| Weride IncSPONSORED ADS · shares New | 8.1% | $24.7M | — | ||||||||
| Total · 5 positions | 100% | $304.5M | −$25.0M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2024 to Q4 2024: 3 stocks held throughout, down $25.0M (−9.2%).
- Recursion Pharmaceuticals In+$1.3M+3%
- Applied Digital Corp−$4.7M−7%
- Arm Holdings Plc−$21.6M−14%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $63.44B+245% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $18.37B+40% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $13.10B+241% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $3.84B−11% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $4.33B+278% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $1.15B+277% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $304.5M−30% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $432.9M+10% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $393.2M+18% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $332.7M+44% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $230.4M | SEC ↗ |